The largest database of trusted experimental protocols

Human immunoglobulin g huigg

Manufactured by MP Biomedicals
Sourced in United States

Human immunoglobulin G (HuIgG) is a purified protein fraction obtained from human plasma. It is the most abundant type of antibody found in the human body, comprising approximately 75% of all serum antibodies. HuIgG plays a crucial role in the body's immune response by recognizing and neutralizing foreign substances, such as bacteria and viruses.

Automatically generated - may contain errors

6 protocols using human immunoglobulin g huigg

1

In Vitro Bevacizumab and Immunoglobulin Study

Check if the same lab product or an alternative is used in the 5 most similar protocols
Bevacizumab was obtained from F. Hoffmann-La Roche Ltd. (Basel, Switzerland). Human immunoglobulin G (HuIgG) was purchased from MP Biomedicals (Santa Ana, CA, USA). Both Bevacizumab and HuIgG were diluted with normal saline. Na-pyruvate and Geneticin™ Selective Antibiotic (G418 Sulfate) were purchased from Thermo Fisher Scientific, Inc. (Waltham, MA, USA). RPMI-1640 culture medium, d-glucose, and HEPES buffer were obtained from Sigma-Aldrich (St. Louis, MO, USA). Fetal bovine serum was obtained from Bovogen Biologicals Pty. Ltd. (Melbourne, Australia).
+ Open protocol
+ Expand
2

Erlotinib and Bevacizumab Drug Preparation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Erlotinib was provided by F. Hoffmann-La Roche Ltd. (Basel, Switzerland) and was dissolved in 6% Captisol solution (ChemScene, Monmouth Junction, NJ, USA). Bevacizumab was obtained from F. Hoffmann-La Roche Ltd. Human immunoglobulin G (HuIgG) was purchased from MP Biomedicals (Santa Ana, CA, USA). Both Bevacizumab and HuIgG were diluted with saline.
+ Open protocol
+ Expand
3

Combination Therapy Dosage Protocols

Check if the same lab product or an alternative is used in the 5 most similar protocols
Bevacizumab was manufactured by Chugai Pharmaceutical Co., Ltd. (Tokyo, Japan) as a solution and diluted to 5 mg/kg body weight (0.2 ml/mouse) with saline. Human immunoglobulin G (HuIgG) was purchased from MP Biomedicals, LLC (Santa Ana, CA, USA), and was reconstituted with water and diluted to 5 mg/kg body weight (0.2 ml/mouse) with saline (Otsuka Pharmaceutical Co., Ltd., Tokyo, Japan). Paclitaxel was purchased from Wako Pure Chemical Industries, Ltd. (Osaka, Japan) and was reconstituted with 50% ethanol-50% Cremophor EL, and immediately prior to administration was diluted 10-fold with saline. PEGylated liposomal doxorubicin was purchased from Janssen Pharmaceutical, Inc. (Beerse, Belgium) as a solution and diluted to 20 mg/kg body weight (10 ml/kg body weight) with saline.
+ Open protocol
+ Expand
4

Preparation of Therapeutic Antibodies and Cytotoxic Agents

Check if the same lab product or an alternative is used in the 5 most similar protocols
Trastuzumab and pertuzumab were provided by F. Hoffmann-La Roche (Basel, Switzerland) as a fine powder and a liquid, respectively. Trastuzumab was dissolved in distilled water. The two antibodies were then diluted with saline for the in vivo experiments and culture medium for the in vitro experiments. Human immunoglobulin G (HuIgG) was purchased from MP Biomedicals, LLC (Solon, OH, USA) and was reconstituted with distilled water and diluted with saline. Docetaxel was purchased from Sanofi K.K. (Tokyo, Japan) and was diluted with saline just before administration. Paclitaxel was purchased from Wako Pure Chemical Industries, Ltd. (Osaka, Japan) as a fine powder. Paclitaxel was reconstituted with Cremophor EL-ethanol solution (1:1) and diluted tenfold with saline just before administration.
+ Open protocol
+ Expand
5

Combination Therapy Evaluation Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
T-DM1, TRAS, and PER were provided by Chugai Pharmaceutical Co., Ltd. Human immunoglobulin G (HuIgG) was purchased from MP Biomedicals, LLC. TRAS and HuIgG were dissolved in distilled water. All agents were diluted with saline for in vivo experiments and with culture medium for in vitro experiments. CAPE, obtained from Chugai Pharmaceutical Co., Ltd., was suspended in 40 mmol/L citrate buffer (pH 6.0) containing 5% gum Arabic as the vehicle. DM1-CH3 was purchased from Toronto Research Chemicals.
+ Open protocol
+ Expand
6

Bevacizumab and Capecitabine Combination Treatment

Check if the same lab product or an alternative is used in the 5 most similar protocols
Bevacizumab and capecitabine were provided by F. Hoffmann-La Roche (Basel, Switzerland) as a liquid and fine powder, respectively. Human immunoglobulin G (HuIgG) was purchased from MP Biomedicals (Solon, OH, USA). capecitabine was dissolved in 40 mM citrate buffer (pH 6.0) containing 5% gum arabic (capecitabine vehicle).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!